Yellowstone Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Yellowstone Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,950	Closed	-$255K	–	214
2017 Q3	$255K	Buy	+2,950	New	+$237K	0.13%	151
2016 Q3	$292K	Sell	4,400 -520	-11%	-$32.2K	0.11%	169
2016 Q2	$266K	Hold	4,920	–	–	0.11%	148
2016 Q1	$254K	Hold	4,920	–	–	0.11%	156
2015 Q4	$345K	Hold	4,920	–	–	0.16%	117
2015 Q3	$306K	Sell	4,920 -30	-0.6%	-$2.36K	0.14%	128
2015 Q2	$416K	Sell	4,950 -900	-15%	-$70K	0.19%	97
2015 Q1	$440K	Buy	5,850 +30	+0.5%	+$2.1K	0.22%	96
2014 Q4	$362K	Hold	5,820	–	–	0.2%	101
2014 Q3	$303K	Hold	5,820	–	–	0.17%	113
2014 Q2	$299K	Buy	+5,820	New	+$262K	0.17%	115

Other funds holding XBI

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Yellowstone Partners's XBI Position: Q4 2017 in Review

Yellowstone Partners sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2017, closing a stake of 2,950 shares — an estimated $255K sold.

Yellowstone Partners first reported a position in XBI in Q2 2014 and held it in 11 quarters. The position peaked at $440K in Q1 2015. 397 funds tracked by Wall St. Rank hold XBI as of Q4 2017.

Yellowstone Partners reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2017 after selling out during the quarter.
Yellowstone Partners sold 2,950 State Street SPDR S&P Biotech ETF shares in Q4 2017, an estimated $255K.
Yellowstone Partners first reported a position in State Street SPDR S&P Biotech ETF in Q2 2014 and held it in 11 quarters.
Yellowstone Partners's State Street SPDR S&P Biotech ETF position peaked at $440K in Q1 2015.
397 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2017.

Based on Yellowstone Partners's 13F filing for Q4 2017, filed 24 Jan 2018.